These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6296358)

  • 1. Relative involvement of receptor subtypes in opioid-induced inhibition of gastrointestinal transit in mice.
    Ward SJ; Takemori AE
    J Pharmacol Exp Ther; 1983 Feb; 224(2):359-63. PubMed ID: 6296358
    [No Abstract]   [Full Text] [Related]  

  • 2. Relative involvement of receptor subtypes in opioid-induced inhibition of intestinal motility in mice.
    Ward SJ; Takemori AE
    Life Sci; 1982 Sep 20-27; 31(12-13):1267-70. PubMed ID: 6128653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spinal cord as a site of opioid effects on gastrointestinal transit in the mouse.
    Porreca F; Burks TF
    J Pharmacol Exp Ther; 1983 Oct; 227(1):22-7. PubMed ID: 6312019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the receptor constants of morphine and ethylketocyclazocine for analgesia and inhibition of gastrointestinal transit in the rat.
    Porreca F; Raffa RB; Cowan A; Tallarida RJ
    Life Sci; 1982 Nov; 31(18):1955-61. PubMed ID: 6294424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibitory effects of ethylketocyclazocine on reflex pathways to the external urethral sphincter of the cat.
    Thor KB; Hisamitsu T; Roppolo JR; Tuttle P; Nagel J; deGroat WC
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1018-25. PubMed ID: 2539452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists.
    Portoghese PS; Lipkowski AW; Takemori AE
    Life Sci; 1987 Mar; 40(13):1287-92. PubMed ID: 2882399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereospecific inhibition of oxotremorine-induced antinociception by (+)-isomers of opioid antagonists: comparison with opioid receptor agonists.
    Ben-Sreti MM; Sewell RD
    J Pharm Pharmacol; 1982 Aug; 34(8):501-5. PubMed ID: 6126560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Only one pharmacophore is required for the kappa opioid antagonist selectivity of norbinaltorphimine.
    Portoghese PS; Nagase H; Takemori AE
    J Med Chem; 1988 Jul; 31(7):1344-7. PubMed ID: 2838632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective antagonists at the opiate delta-receptor.
    Shaw JS; Miller L; Turnbull MJ; Gormley JJ; Morley JS
    Life Sci; 1982 Sep 20-27; 31(12-13):1259-62. PubMed ID: 6128652
    [No Abstract]   [Full Text] [Related]  

  • 10. Nonequilibrium opioid antagonist activity of 6,14-dideoxynaltrexone derivatives.
    Schoenecker JW; Takemori AE; Portoghese PS
    J Med Chem; 1987 Jun; 30(6):1040-4. PubMed ID: 3035177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered opiate receptor binding in synaptosomes: implication of phosphorylation.
    Stokes KB; Loh HH
    Proc West Pharmacol Soc; 1984; 27():423-7. PubMed ID: 6093135
    [No Abstract]   [Full Text] [Related]  

  • 12. Upregulation of opioid receptor subtypes correlates with potency changes of morphine and DADLE.
    Yoburn BC; Luke MC; Pasternak GW; Inturrisi CE
    Life Sci; 1988; 43(16):1319-24. PubMed ID: 2845219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The influence of piracetam on the effects of narcotic analgesics].
    Chichenkov ON; Krylova IN; Borozdin MIu; Pokatilov DV
    Farmakol Toksikol; 1990; 53(2):22-4. PubMed ID: 1973390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus effects of prototype opiate receptor agonists in monkeys.
    Teal JJ; Holtzman SG
    Eur J Pharmacol; 1980 Nov; 68(1):1-10. PubMed ID: 6256182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous assessment of the opiate-induced modifications in the vertical and horizontal components of locomotor activity in mice.
    Chaillet P; Durand MA; Marçais-Collado H; Costentin J
    J Pharmacol; 1984; 15(3):375-83. PubMed ID: 6092786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human psychopharmacology of ketocyclazocine as compared with cyclazocine, morphine and placebo.
    Kumor KM; Haertzen CA; Johnson RE; Kocher T; Jasinski D
    J Pharmacol Exp Ther; 1986 Sep; 238(3):960-8. PubMed ID: 3018228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynorphin(1-13), a long-lasting inhibitor of opiate receptor binding in vitro.
    Garzón J; Jen MF; Sánchez-Blázquez P; Lee NM
    Life Sci; 1982 Oct 18-25; 31(16-17):1789-92. PubMed ID: 6130441
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies of kappa agonist.
    Kumor K; Su TP; Vaupel B; Haertzen C; Johnson RE; Goldberg S
    NIDA Res Monogr; 1986; 67():18-25. PubMed ID: 3018572
    [No Abstract]   [Full Text] [Related]  

  • 19. [Differences in opioid binding in the left and right visual cortex of the turtle].
    Kobylianskiĭ AG; Pivovarov AS; Nesterenko PN; Iarygin KN; Bakalkin GIa
    Dokl Akad Nauk SSSR; 1986; 291(2):479-83. PubMed ID: 3024944
    [No Abstract]   [Full Text] [Related]  

  • 20. Different modes of opiate interaction in rat vas deferens.
    Sánchez-Blázquez P; Garzón J; Lee NM
    Life Sci; 1982 Oct 18-25; 31(16-17):1683-6. PubMed ID: 6759825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.